Arvee Laboratories (India) share news and announcements
NSE: ARVEEChemicals & PetrochemicalsSmall Cap
Last close ₹189.07down ₹8.31 (4.21%)
Share price at the NSE close on 23 Oct 2026. Previous close ₹197.38.
52-week range of traded prices to 23 Oct 2026
₹129.11Low, 30 Mar 2026₹290.78High, 19 Dec 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and other business matters.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹208 Cr2,476th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 7 Aug 2026
- 51.4
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 19 May 2026
- 6.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 7 Aug 2026
- 12.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- 11.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 19 May 2026
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,57751.7% delivered
Arvee Laboratories (India) share news and announcements
259 announcements, routine notices left out, newest first. Page 3 of 6.
Jul 2022
13 Jul · General updates
7 Jul · Legal
The exchange asked on 6 Jul 2022
Jun 2022
4 Jun · Related Party Transaction
May 2022
Apr 2022
Mar 2022
12 Mar · Legal
The exchange asked on 11 Mar 2022
Feb 2022
Jan 2022
Nov 2021
Oct 2021
4 Oct · Disclosure under SEBI (PIT) Reg 2015
2 Oct · Management
Sep 2021
17 Sep · Management
Aug 2021
Jul 2021
19 Jul · Legal
Exchange has sought clarification from Arvee Laboratories (India) Limited with respect to announcement dated 17-Jul-2021, regarding board meeting held on July 17, 2021. On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment of internal auditor) The response of the Company is awaited.17 Jul · Management
17 Jul · Management
17 Jul · Updates
17 Jul · Board meeting